News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jenne Kyle
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2020 |
4
| Jenne Kyle (Chief Commercial Officer) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Unknown transaction of 52,012 shares
@ $18.15, valued at
$944k
Disposed/sold 143,374 options to buy
@ $12.21, valued at
$1.8M
Disposed/sold 32,751 options to buy
@ $12.21, valued at
$399.9k
Disposed/sold 299 options to buy
@ $17.38, valued at
$5.2k
Disposed/sold 13,701 options to buy
@ $17.38, valued at
$238.1k
Disposed/sold 34,200 options to buy
@ $12.76, valued at
$436.4k
|
|
| 09/24/2020 |
4
| Jenne Kyle (Chief Commercial Officer) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 720 shares
@ $18.12, valued at
$13k
|
|
| 03/25/2020 |
4
| Jenne Kyle (Chief Commercial Officer) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 779 shares
@ $11.7503, valued at
$9.2k
|
|
| 03/23/2020 |
4
| Jenne Kyle (Chief Commercial Officer) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 16,800 shares
@ $0
Granted 34,200 options to buy
@ $12.76, valued at
$436.4k
|
|
| 10/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/23/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|